Basic Information
RNALocate ID: | RLID:11002823 |
RNA Symbol: | hsa-miR-451a |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-451 |
RNA ID: | miRBase:MIMAT0001631 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20976003 |
Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
Method: | Microarray |
Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11002818 | Exosome | Primary T lymphocytes | 24356509 |
RLID:11002819 | Exosome | Plasma | 29130611 |
RLID:11002820 | Exosome | Peripheral blood|Portal vein blood | 30561106 |
RLID:11002821 | Exosome | Serum | 18589210 |
RLID:11002822 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002824 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11002825 | Exosome | Renal cancer cells | 21670082 |
RLID:11002826 | Exosome | HCC cell line (Hep3B|HepG2|PLC/PRF/5) | 21721029 |
RLID:11002827 | Exosome | Brain tissue | 23382797 |
RLID:11002828 | Exosome | Plasma | 23663360 |
RLID:11002829 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002830 | Exosome | Plasma | 24130905 |
RLID:11002831 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11002832 | Extracellular Vesicle | Liposarcoma cell lines (Lipo224B|Lipo246|Lipo863|LPS141)|Preadipocytes | 28588009 |
RLID:11002833 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11002834 | Extracellular vesicle | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11002835 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002836 | Microvesicle | Liver resident stem cells|Mesenchymal stem cells | 20668554 |
RLID:11002837 | Microvesicle | Plasma | 23077538 |
RLID-D:11000144 | Exosome | Blood|B lymphoblastoid cells|Endothelial cells|Lymphoma tissue|Mast cells | |
RLID-D:11000461 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-mir-451a | Pterygium | MNDR-E-MI-51116 |
MNDR | hsa-mir-451a | Adult T cell leukemia | MNDR-E-MI-51117 |
MNDR | hsa-miR-451a | Large cell neuroendocrine cancer | MNDR-E-MI-51118 |
MNDR | hsa-miR-451a | Follicular lymphoma | MNDR-E-MI-51119 |
MNDR | hsa-miR-451a | Medulloblastoma | MNDR-E-MI-51120 |
MNDR | hsa-miR-451a | High-grade serous ovarian carcinoma | MNDR-E-MI-51121 |
MNDR | hsa-miR-451a | Ovarian clear cell carcinoma | MNDR-E-MI-51122 |
MNDR | hsa-miR-451a | Uterine corpus endometrial carcinoma | MNDR-E-MI-51123 |
MNDR | hsa-miR-451a | Lymphoma | MNDR-E-MI-51124 |
MNDR | hsa-miR-451a | Estrogen-receptor positive breast cancer | MNDR-E-MI-51125 |
MNDR | hsa-miR-451a | Estrogen-receptor negative breast cancer | MNDR-E-MI-51126 |
MNDR | hsa-miR-451a | Progesterone-receptor positive breast cancer | MNDR-E-MI-51127 |
MNDR | hsa-miR-451a | Progesterone-receptor negative breast cancer | MNDR-E-MI-51128 |
MNDR | hsa-miR-451a | Her2-receptor positive breast cancer | MNDR-E-MI-51129 |
MNDR | hsa-miR-451a | Breast cancer luminal | MNDR-E-MI-51130 |
MNDR | hsa-miR-451a | Anencephaly | MNDR-E-MI-51131 |
MNDR | hsa-miR-451a | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-51132 |
MNDR | hsa-mir-451a | Colorectal carcinoma | MNDR-E-MI-51133 |
MNDR | hsa-miR-451a | Fatty liver non-alcoholic | MNDR-E-MI-51134 |
MNDR | hsa-mir-451a | Fatty liver non-alcoholic | MNDR-E-MI-51135 |
MNDR | hsa-mir-451a | Acth-independent macronodular adrenal hyperplasia; aimah | MNDR-E-MI-51136 |
MNDR | hsa-miR-451a | Prostate cancer | MNDR-E-MI-51137 |
MNDR | hsa-mir-451a | Early-stage gastric carcinoma | MNDR-E-MI-51138 |
MNDR | hsa-miR-451a | Gastric cancer | MNDR-E-MI-51139 |
MNDR | hsa-miR-451a | Alzheimer disease | MNDR-E-MI-51140 |
MNDR | hsa-miR-451a | Sickle cell anemia | MNDR-E-MI-51141 |
MNDR | hsa-mir-451a | Sickle cell diseases | MNDR-E-MI-51142 |
MNDR | hsa-miR-451a | Intracranial aneurysm | MNDR-E-MI-51143 |
MNDR | hsa-mir-451a | Bladder cancer | MNDR-E-MI-51144 |
MNDR | hsa-miR-451a | Esophageal carcinoma | MNDR-E-MI-51145 |
MNDR | hsa-mir-451a | Esophageal carcinoma | MNDR-E-MI-51146 |
MNDR | hsa-miR-451a | Sarcoma | MNDR-E-MI-51147 |
MNDR | hsa-miR-451a | Dysautonomia familial | MNDR-E-MI-51148 |
MNDR | hsa-miR-451a | Seizures | MNDR-E-MI-51149 |
MNDR | hsa-miR-451a | Head and neck cancer | MNDR-E-MI-51150 |
MNDR | hsa-miR-451a | Hypertrophic cardiomyopathy | MNDR-E-MI-51151 |
MNDR | hsa-miR-451a | Primary biliary cirrhosis | MNDR-E-MI-51152 |
MNDR | hsa-miR-451a | Malaria | MNDR-E-MI-51153 |
MNDR | hsa-mir-451a | Malaria | MNDR-E-MI-51154 |
MNDR | hsa-miR-451a | Leukemia | MNDR-E-MI-51155 |
MNDR | hsa-mir-451a | Leiomyoma | MNDR-E-MI-51156 |
MNDR | hsa-miR-451a | Huntington disease | MNDR-E-MI-51157 |
MNDR | hsa-miR-451a | Chorea | MNDR-E-MI-51158 |
MNDR | hsa-miR-451a | Cardiovascular disease | MNDR-E-MI-51159 |
MNDR | hsa-mir-451a | Dilated cardiomyopathy | MNDR-E-MI-51160 |
MNDR | hsa-miR-451a | Moyamoya disease | MNDR-E-MI-51161 |
MNDR | hsa-miR-451a | Brain cancer | MNDR-E-MI-51162 |
MNDR | hsa-miR-451a | Uterine fibroid | MNDR-E-MI-51163 |
MNDR | hsa-mir-451a | Lung cancer | MNDR-E-MI-51164 |
MNDR | hsa-miR-451a | Lung cancer | MNDR-E-MI-51165 |
MNDR | hsa-miR-451a | Down syndrome | MNDR-E-MI-51166 |
MNDR | hsa-miR-451a | Parkinson disease | MNDR-E-MI-51167 |
MNDR | hsa-miR-451a | Major depressive disorder | MNDR-E-MI-51168 |
MNDR | hsa-miR-451a | Basal-like breast cancer | MNDR-E-MI-51169 |
MNDR | hsa-mir-451a | Breast cancer | MNDR-E-MI-51170 |
MNDR | hsa-mir-451a | Neoplasms | MNDR-E-MI-51171 |
MNDR | hsa-mir-451a | Squamous cell carcinoma | MNDR-E-MI-51172 |
MNDR | hsa-miR-451a | Thyroid cancer | MNDR-E-MI-51173 |
MNDR | hsa-miR-451a | Pituitary neoplasms | MNDR-E-MI-51174 |
MNDR | hsa-mir-451a | Pancreatic cancer | MNDR-E-MI-51175 |
MNDR | hsa-miR-451a | Pancreatic cancer | MNDR-E-MI-51176 |
MNDR | hsa-mir-451a | Supravalvar aortic stenosis | MNDR-E-MI-51177 |
MNDR | hsa-miR-451a | Rectum adenocarcinoma | MNDR-E-MI-51178 |
MNDR | hsa-miR-451a | Nephroblastoma | MNDR-E-MI-51179 |
MNDR | hsa-miR-451a | Colon cancer | MNDR-E-MI-51180 |
MNDR | hsa-mir-451a | Colon cancer | MNDR-E-MI-51181 |
MNDR | hsa-miR-451a | Ischemic attack transient | MNDR-E-MI-51182 |
MNDR | hsa-miR-451a | Colon adenocarcinoma | MNDR-E-MI-51183 |
MNDR | hsa-miR-451a | Multiple sclerosis relapsing-remitting | MNDR-E-MI-51184 |
MNDR | hsa-miR-451a | Familial ovarian cancer | MNDR-E-MI-51185 |
MNDR | hsa-mir-451a | Ovarian cancer | MNDR-E-MI-51186 |
MNDR | hsa-mir-451a | Basal cell carcinoma | MNDR-E-MI-51187 |
MNDR | hsa-miR-451a | Prostate adenocarcinoma | MNDR-E-MI-51188 |
MNDR | hsa-miR-451a | Thyroid adenomas | MNDR-E-MI-51189 |
MNDR | hsa-mir-451a | Pulmonary tuberculosis | MNDR-E-MI-51190 |
MNDR | hsa-miR-451a | Carcinoma ductal breast | MNDR-E-MI-51191 |
MNDR | hsa-miR-451a | Glioblastoma | MNDR-E-MI-51192 |
MNDR | hsa-mir-451a | Glioblastoma | MNDR-E-MI-51193 |
MNDR | hsa-mir-451a | Glioblastoma multiforme somatic | MNDR-E-MI-51194 |
MNDR | hsa-miR-451a | Glioma | MNDR-E-MI-51195 |
MNDR | hsa-mir-451a | Glioma | MNDR-E-MI-51196 |
MNDR | hsa-miR-451a | Chronic obstructive pulmonary disease | MNDR-E-MI-51197 |
MNDR | hsa-mir-451a | Gastrointestinal neoplasms | MNDR-E-MI-51198 |
MNDR | hsa-miR-451a | Amyotrophic lateral sclerosis | MNDR-E-MI-51199 |
MNDR | hsa-miR-451a | Epilepsy temporal lobe | MNDR-E-MI-51200 |
MNDR | hsa-miR-451a | Osteosarcoma | MNDR-E-MI-51201 |
MNDR | hsa-mir-451a | Osteosarcoma | MNDR-E-MI-51202 |
MNDR | hsa-miR-451a | Liposarcoma | MNDR-E-MI-51203 |
MNDR | hsa-mir-451a | Liposarcoma | MNDR-E-MI-51204 |
MNDR | hsa-miR-451a | Breast carcinoma | MNDR-E-MI-51205 |
MNDR | hsa-miR-451a | Meningioma | MNDR-E-MI-51206 |
MNDR | hsa-miR-451a | Liver cancer | MNDR-E-MI-51207 |
MNDR | hsa-mir-451a | Mucinous cystadenocarcinoma | MNDR-E-MI-51208 |
MNDR | hsa-miR-451a | Cervical adenocarcinoma | MNDR-E-MI-51209 |
MNDR | hsa-miR-451a | Gastric adenocarcinoma | MNDR-E-MI-51210 |
MNDR | hsa-miR-451a | Cervical squamous cell carcinoma | MNDR-E-MI-51211 |
MNDR | hsa-miR-451a | Pituitary adenoma | MNDR-E-MI-51212 |
MNDR | hsa-miR-451a | Lung squamous cell carcinoma | MNDR-E-MI-51213 |
MNDR | hsa-mir-451a | Carcinoma lung non-small-cell | MNDR-E-MI-51214 |
MNDR | hsa-miR-451a | Non-small cell lung cancer | MNDR-E-MI-51215 |
MNDR | hsa-miR-451a | Lung adenocarcinoma | MNDR-E-MI-51216 |
MNDR | hsa-mir-451a | Lung adenocarcinoma | MNDR-E-MI-51217 |
MNDR | hsa-miR-451a | Thyroid carcinoma | MNDR-E-MI-51218 |
MNDR | hsa-mir-451a | Papillary thyroid carcinoma | MNDR-E-MI-51219 |
MNDR | hsa-miR-451a | Ovarian carcinoma | MNDR-E-MI-51220 |
MNDR | hsa-miR-451a | Bladder urothelial carcinoma | MNDR-E-MI-51221 |
MNDR | hsa-miR-451a | Pancreatic adenocarcinoma | MNDR-E-MI-51222 |
MNDR | hsa-mir-451a | Cervical cancer | MNDR-E-MI-51223 |
MNDR | hsa-miR-451a | Myasthenia gravis autoimmune experimental | MNDR-E-MI-51224 |
MNDR | hsa-miR-451a | Carcinoma renal cell | MNDR-E-MI-51225 |
MNDR | hsa-mir-451a | Renal cell carcinoma | MNDR-E-MI-51226 |
MNDR | hsa-miR-451a | Kidney renal papillary cell carcinoma | MNDR-E-MI-51227 |
MNDR | hsa-miR-451a | Renal clear cell carcinoma | MNDR-E-MI-51228 |
MNDR | hsa-miR-451a | Large cell carcinoma | MNDR-E-MI-51229 |
MNDR | hsa-miR-451a | Biliary tract cancer | MNDR-E-MI-51230 |
MNDR | hsa-miR-451a | Intrahepatic cholangiocarcinoma | MNDR-E-MI-51231 |
MNDR | hsa-miR-451a | Cholangiocarcinoma | MNDR-E-MI-51232 |
MNDR | hsa-mir-451a | Esophageal cancer | MNDR-E-MI-51233 |
MNDR | hsa-miR-451a | Esophageal cancer | MNDR-E-MI-51234 |
MNDR | hsa-miR-451a | Liver cirrhosis | MNDR-E-MI-51235 |
MNDR | hsa-miR-451a | Prolactinoma | MNDR-E-MI-51236 |
MNDR | hsa-miR-451a | Lung small cell carcinoma | MNDR-E-MI-51237 |
MNDR | hsa-miR-451a | Head and neck squamous cell carcinoma | MNDR-E-MI-51238 |
MNDR | hsa-mir-451a | Head and neck squamous cell carcinoma | MNDR-E-MI-51239 |
MNDR | hsa-mir-451a | Myocardial infarction | MNDR-E-MI-51240 |
MNDR | hsa-miR-451a | Fibromyalgia | MNDR-E-MI-51241 |
MNDR | hsa-mir-451a | Pulmonary hypertension | MNDR-E-MI-51242 |
MNDR | hsa-miR-451a | Adenoma | MNDR-E-MI-51243 |
MNDR | hsa-miR-451a | Breast invasive carcinoma | MNDR-E-MI-51244 |
MNDR | hsa-mir-451a | Carcinoma hepatocellular | MNDR-E-MI-51245 |
MNDR | hsa-miR-451a | Early hepatocellular carcinoma | MNDR-E-MI-51246 |
MNDR | hsa-miR-451a | Embryonal cancer | MNDR-E-MI-51247 |
MNDR | hsa-miR-451a | Familiar ovarian carcinoma | MNDR-E-MI-51248 |
MNDR | hsa-mir-451a | Precursor b-cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-51249 |
MNDR | hsa-miR-451a | B-cell lymphoma | MNDR-E-MI-51250 |
MNDR | hsa-mir-451a | Rheumatoid arthritis | MNDR-E-MI-51251 |
MNDR | hsa-miR-451a | Rheumatoid arthritis | MNDR-E-MI-51252 |
MNDR | hsa-mir-451a | Hypopharyngeal cancer | MNDR-E-MI-51253 |
MNDR | hsa-mir-451a | Gastroesphageal reflux | MNDR-E-MI-51254 |
MNDR | hsa-miR-451a | Chronic myelogenous leukemia | MNDR-E-MI-51255 |
MNDR | hsa-mir-451a | Chronic myelogenous leukemia | MNDR-E-MI-51256 |
MNDR | hsa-miR-451a | Neuromyelitis optica | MNDR-E-MI-51257 |
MNDR | hsa-mir-451a | Polycythemia vera | MNDR-E-MI-51258 |
MNDR | hsa-miR-451a | Acute myelocytic leukemia | MNDR-E-MI-51259 |
MNDR | hsa-mir-451a | Acute myeloid leukemia | MNDR-E-MI-51260 |
MNDR | hsa-miR-451a | Colorectal cancer | MNDR-E-MI-51261 |
MNDR | hsa-mir-451a | Colorectal cancer | MNDR-E-MI-51262 |
MNDR | hsa-mir-451a | Carcinoma nasopharyngeal | MNDR-E-MI-51263 |
MNDR | hsa-mir-451a | Nasopharynx carcinoma | MNDR-E-MI-51264 |
MNDR | hsa-miR-451a | Tyrosinemias | MNDR-E-MI-51265 |
MNDR | hsa-miR-451a | Leukemia lymphoblastic acute | MNDR-E-MI-51266 |
MNDR | hsa-mir-451a | Diabetic nephropathies | MNDR-E-MI-51267 |
MNDR | hsa-miR-451a | Ependymoma | MNDR-E-MI-51268 |
MNDR | hsa-mir-451a | Erythropoiesis | MNDR-E-MI-51269 |
MNDR | hsa-miR-451a | Hearing loss noise-induced | MNDR-E-MI-51270 |
MNDR | hsa-miR-451a | Cardiomegaly | MNDR-E-MI-51271 |
MNDR | hsa-mir-451a | Infection | MNDR-E-MI-51272 |
MNDR | hsa-miR-451a | Nasopharyngeal cancer | MNDR-E-MI-51273 |
MNDR | hsa-mir-451a | Trophoblasts | MNDR-E-MI-51274 |
MNDR | hsa-mir-451a | Retinal neovascularization | MNDR-E-MI-51275 |
MNDR | hsa-mir-451a | Ischemic heart disease | MNDR-E-MI-51276 |
MNDR | hsa-miR-451a | Subarachnoid hemorrhage traumatic | MNDR-E-MI-51277 |
MNDR | hsa-miR-451a | Stroke lacunar | MNDR-E-MI-51278 |
MNDR | hsa-mir-451a | Non-alcoholic fatty liver disease | MNDR-E-MI-51279 |
MNDR | hsa-miR-451a | Breast cancer her3+ negative | MNDR-E-MI-51280 |
MNDR | hsa-miR-451a | High grade dysplastic nodule | MNDR-E-MI-51281 |
MNDR | hsa-mir-451a | Hypopharyngeal squamous cell carcinoma | MNDR-E-MI-51282 |
MNDR | hsa-mir-451a | Stroke susceptibility | MNDR-E-MI-51283 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022787 |
TOP